- Home
- » Tags
- » Mitoxantrone
Top View
- Molecular Remission and Reconstitution of a Full Chimera With
- Acronyms for Oncology Regimens
- Antitumor Antibiotics
- Derivation of Anthracycline Equivalence to Doxorubicin in Relation to Late Cardiotoxicity: Epirubicin, Idarubicin and Mitoxantrone
- Evidence Tables Cardiomyopathy Surveillance
- Secondary Myelodysplastic Syndrome/Acute Myeloid Leukaemia
- Marked Leukocytosis in Response to Estramustine Phosphate in a Hormone-Refractory Prostate Cancer Patient
- Combination Chemotherapy with Docetaxel, Vinorelbine and Estramustine Phosphate in Metastatic Androgen-Resistant Prostate Cancer: a Single Institution Experience
- A Thesis Entitled Metal Binding Characteristics of Heterocyclic and Carbocyclic Anticancer Drugs by Brittany Bezoski Submitted T
- Estramustine Phosphate Induces PC3 Apoptosis in Prostate Cancer Occurrence and Development
- Cladribine in the Treatment of Multiple Sclerosis
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- Mitoxantrone | Memorial Sloan Kettering Cancer Center
- Comparative Study of Doxorubicin, Mitoxantrone, and Epirubicin in Combination with ICRF-187 (ADR-529) in a Chronic Cardiotoxicity Animal Model'
- High-Dose Mitoxantrone and Cyclophosphamide Without Stem Cell Support in High-Risk and Advanced Solid Tumors: a Phase I Trial
- Randomized Trial of Intermediate-Dose Cytarabine In
- Adult Antiemetic Management of Chemotherapy-Induced Nausea
- Cladribine Combined with Cyclophosphamide and Mitoxantrone As Front-Line Therapy in Chronic Lymphocytic Leukemia
- List Item Novantrone Article-30 Referral
- ©Ferrata Storti Foundation
- Proposal for the Inclusion of Arsenic Therapies in the WHO Model List of ESSENTIAL MEDICINES for the Treatment of Acute Promyelocytic Leukemia
- Mitomycin C and Mitoxantrone Chemotherapy for Advanced Breast Cancer: Efficacy with Minimal Gastrointestinal Toxicity and Alopecia*
- Mitoxantrone
- Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
- Antitumour Treatment: Mitomycin C: a Clinical Update
- Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
- RITUXIMAB-VINCRISTINE (Rpmitcebo)
- Cladribine in the Remission Induction of Adult Acute Myeloid Leukemia: Where Do We Stand?
- A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia Anjali S
- (Novantrone) for the Treatment of Multiple Sclerosis Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
- Novel Homobarringtonie‑Containing Therapy for the Treatment of Patients with Primary Acute Myeloid Leukemia That Are Resistant to Conventional Therapy
- Neuro-Oncology Provided by AIR Universita Degli Studi Di Milano Neuro-Oncology 16(5), 719–727, 2014 Doi:10.1093/Neuonc/Not316 Advance Access Date 23 January 2014
- 203469Orig1s000
- Phase I/II Trial of Cladribine, High-Dose Cytarabine, Mitoxantrone, and G
- CE SESHP Chemo Agents
- DRUG NAME: Mitoxantrone
- University of Illinois Cancer Center Confidential AML-02: Study of the Activity and Safety of the Addition of Omacetaxine To
- Trisenox,INN-Arsenic Trioxide
- Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML